Cargando…
Fragile X Syndrome in children
Fragile X syndrome is caused by the expansion of CGG triplets in the FMR1 gene, which generates epigenetic changes that silence its expression. The absence of the protein coded by this gene, FMRP, causes cellular dysfunction, leading to impaired brain development and functional abnormalities. The ph...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universidad del Valle
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469670/ https://www.ncbi.nlm.nih.gov/pubmed/37664646 http://dx.doi.org/10.25100/cm.v54i2.5089 |
_version_ | 1785099493797003264 |
---|---|
author | Acero-Garcés, David O. Saldarriaga, Wilmar Cabal-Herrera, Ana M. Rojas, Christian A. Hagerman, Randi J. |
author_facet | Acero-Garcés, David O. Saldarriaga, Wilmar Cabal-Herrera, Ana M. Rojas, Christian A. Hagerman, Randi J. |
author_sort | Acero-Garcés, David O. |
collection | PubMed |
description | Fragile X syndrome is caused by the expansion of CGG triplets in the FMR1 gene, which generates epigenetic changes that silence its expression. The absence of the protein coded by this gene, FMRP, causes cellular dysfunction, leading to impaired brain development and functional abnormalities. The physical and neurologic manifestations of the disease appear early in life and may suggest the diagnosis. However, it must be confirmed by molecular tests. It affects multiple areas of daily living and greatly burdens the affected individuals and their families. Fragile X syndrome is the most common monogenic cause of intellectual disability and autism spectrum disorder; the diagnosis should be suspected in every patient with neurodevelopmental delay. Early interventions could improve the functional prognosis of patients with Fragile X syndrome, significantly impacting their quality of life and daily functioning. Therefore, healthcare for children with Fragile X syndrome should include a multidisciplinary approach. |
format | Online Article Text |
id | pubmed-10469670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Universidad del Valle |
record_format | MEDLINE/PubMed |
spelling | pubmed-104696702023-09-01 Fragile X Syndrome in children Acero-Garcés, David O. Saldarriaga, Wilmar Cabal-Herrera, Ana M. Rojas, Christian A. Hagerman, Randi J. Colomb Med (Cali) Review Fragile X syndrome is caused by the expansion of CGG triplets in the FMR1 gene, which generates epigenetic changes that silence its expression. The absence of the protein coded by this gene, FMRP, causes cellular dysfunction, leading to impaired brain development and functional abnormalities. The physical and neurologic manifestations of the disease appear early in life and may suggest the diagnosis. However, it must be confirmed by molecular tests. It affects multiple areas of daily living and greatly burdens the affected individuals and their families. Fragile X syndrome is the most common monogenic cause of intellectual disability and autism spectrum disorder; the diagnosis should be suspected in every patient with neurodevelopmental delay. Early interventions could improve the functional prognosis of patients with Fragile X syndrome, significantly impacting their quality of life and daily functioning. Therefore, healthcare for children with Fragile X syndrome should include a multidisciplinary approach. Universidad del Valle 2023-05-20 /pmc/articles/PMC10469670/ /pubmed/37664646 http://dx.doi.org/10.25100/cm.v54i2.5089 Text en Copyright © 2023 Colombia Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Review Acero-Garcés, David O. Saldarriaga, Wilmar Cabal-Herrera, Ana M. Rojas, Christian A. Hagerman, Randi J. Fragile X Syndrome in children |
title | Fragile X Syndrome in children |
title_full | Fragile X Syndrome in children |
title_fullStr | Fragile X Syndrome in children |
title_full_unstemmed | Fragile X Syndrome in children |
title_short | Fragile X Syndrome in children |
title_sort | fragile x syndrome in children |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469670/ https://www.ncbi.nlm.nih.gov/pubmed/37664646 http://dx.doi.org/10.25100/cm.v54i2.5089 |
work_keys_str_mv | AT acerogarcesdavido fragilexsyndromeinchildren AT saldarriagawilmar fragilexsyndromeinchildren AT cabalherreraanam fragilexsyndromeinchildren AT rojaschristiana fragilexsyndromeinchildren AT hagermanrandij fragilexsyndromeinchildren |